Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026)
Aura Biosciences (AURA) posted Other Non-Current Assets of $517000.0 for Q1 2026, down 32.68% on a QoQ basis from $768000.0 in Q4 2025, and down 32.68% year-over-year from $768000.0 in Q1 2025.
Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Aura Biosciences' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $517000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 32.68% year-over-year to $517000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $517000.0 (down 32.68% YoY) and the FY2025 annual result came in at $768000.0, up 48.26% from the prior year.
- Other Non-Current Assets was $517000.0 for Q1 2026 at Aura Biosciences, down from $768000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $893000.0 in Q2 2022 and bottomed at $125000.0 in Q1 2022.
- A 5-year average of $687764.7 and a median of $768000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 614.4% — and 2026, when it slumped 32.68%.
- Aura Biosciences' Other Non-Current Assets stood at $423000.0 in 2022, then soared by 81.56% to $768000.0 in 2023, then tumbled by 32.55% to $518000.0 in 2024, then soared by 48.26% to $768000.0 in 2025, then tumbled by 32.68% to $517000.0 in 2026.
- Business Quant data shows AURA's Other Non-Current Assets at $517000.0 in Q1 2026, $768000.0 in Q4 2025, and $768000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | 517,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 517,000.00 |
| Dec 31, 2025 | 768,000.00 |
| Sep 30, 2025 | 768,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 768,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | 768,000.00 |
| Dec 31, 2023 | 768,000.00 |
| Sep 30, 2023 | 768,000.00 |
| Jun 30, 2023 | 768,000.00 |
| Mar 31, 2023 | 768,000.00 |
| Dec 31, 2022 | 423,000.00 |
| Sep 30, 2022 | 768,000.00 |
| Jun 30, 2022 | 893,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 125,000.00 |